Story perspectives

Trump's Bold Plan to Cut Drug Prices Faces Doubt

9/13/2025

Summary

Story summary

President Trump seeks to reduce U.S. drug prices by pressuring manufacturers to increase prices abroad, as stated by Commerce Secretary Howard Lutnick.
His plan includes enforcing “Most Favored Nation” pricing, aligning U.S. prices with those in peer countries.
Experts doubt Trump's authority to enforce this and foresee potential legal challenges.
Previous attempts to implement this model faced court blocks and were reversed by the Biden administration.
Trump also intends to impose tariffs on pharmaceutical imports, particularly brand-name drugs.

History

Historical Context

In 1990, Congress established the Medicaid Drug Rebate Program to require pharmaceutical manufacturers to provide rebates for Medicaid purchases. This initiative aimed to control drug costs but faced challenges, including a 10% price increase in 2019 amid the Trump administration's proposed "Most Favored Nation" pricing model. The ongoing debate highlights tensions between healthcare access and pharmaceutical profits, influencing future policy directions.

1 of 2

Story summary

President Trump seeks to reduce U.S. drug prices by pressuring manufacturers to increase prices abroad, as stated by Commerce Secretary Howard Lutnick.
His plan includes enforcing “Most Favored Nation” pricing, aligning U.S. prices with those in peer countries.
Experts doubt Trump's authority to enforce this and foresee potential legal challenges.
Previous attempts to implement this model faced court blocks and were reversed by the Biden administration.
Trump also intends to impose tariffs on pharmaceutical imports, particularly brand-name drugs.

1 / 2